Clinical Trial Update: Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial exploring conversion therapy with sintilimab plus apatinib and chemotherapy in stage IV gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)
• Chemotherapy (chemotherapy)
• Sintilimab (sintilimab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Gastric Cancer Stage IV | Phase 2 | Status: UNKNOWN